OFLOVAS-OZ

OFLOVAS-OZ is a pharmaceutical tablet formulation containing Ofloxacin 200 mg and Ornidazole 500 mg. This combination brings together two active pharmaceutical ingredients with distinct antimicrobial properties. Ofloxacin belongs to the fluoroquinolone class of antibiotics, while Ornidazole is a nitroimidazole derivative with antiprotozoal and activity against susceptible anaerobic microorganisms.

Each tablet contains Ofloxacin 200 mg and Ornidazole 500 mg. The formulation is classified within the anti-diarrheal segment of the SupriMeda pharmaceutical product portfolio and is presented as an oral tablet dosage form. Its defined composition and individual ingredient strengths support accurate product identification, catalogue management and pharmaceutical procurement.

OFLOVAS-OZ is supplied in a pack of 10 strips containing 10 tablets per strip, providing a total of 100 tablets per pack. The product is relevant to pharmaceutical product listings maintained for hospitals, pharmacies, doctors and authorised healthcare procurement professionals.